Monoclonal Antibodies
Links shared publicly online about this topic
Multiple Sclerosis - Monoclonal Antibodies: What Are They?
healthcentral.com — “The Immune System: Invaders and Defenders We are surrounded by billions of bacteria and viruses which try to invade our bodies and reproduce. We call t...” View full resource at healthcentral.com
Most Recently Shared on January 20, 2010 at 4:27 pm By:
Monoclonal Antibodies: What are they?: The Immune System: Invaders and Defenders  We are surrounded by billions o... http://bit.ly/6GqJP5
Brass and Ivory: Monoclonal Antibodies in Development for MS
brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\” View full resource at brassandivory.blogspot.com
Most Recently Shared on February 2, 2010 at 5:42 pm By:
Monoclonal Antibodies in Development for MS: What are some monoclonal antibody treatments in development for MS? ... http://bit.ly/cgw4GH
Brass and Ivory: Rituxan, Tysabri, Zenapax are Monoclonal Antibodies
brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\” View full resource at brassandivory.blogspot.com
Most Recently Shared on January 20, 2010 at 7:53 pm By:
Rituxan, Tysabri, Zenapax are Monoclonal Antibodies: Monoclonal antibodies (MABs) are a type of biological therapy... http://bit.ly/6QAk3h
A Monoclonal Antibody for Multiple Myeloma - Patient Power
patientpower.info — “Dr. Robert Orlowski, from MD Anderson, explains the basics of elotuzumab.” View full resource at patientpower.info
Most Recently Shared on February 20, 2012 at 6:55 pm By:
A Monoclonal Antibody for Multiple Myeloma - Patient Power - http://t.co/IIAVdoEg
Promising Phase 1 Results For New Monoclonal Antibody to PCSK9 - Forbes
forbes.com — “Promising results from very early studies with an experimental new cholesterol-lowering drug, a monoclonal antibody to PCSK9, have been published in the New England Journal of Medicine. Evan Stein and colleagues report the results of two single-dose studies in which the drug, REGN727, was administered intravenously and subcutaneously to healthy subjects. In a [...]” View full resource at forbes.com
Most Recently Shared on March 21, 2012 at 10:15 pm By:
Promising Phase 1 Results For New Monoclonal Antibody to PCSK9: Promising results from very early studies ... http://t.co/WSuhWPVD #drug
Promising Phase 1 Results For New Monoclonal Antibody to PCSK9 - Forbes
forbes.com — “Promising results from very early studies with an experimental new cholesterol-lowering drug, a monoclonal antibody to PCSK9, have been published in the New England Journal of Medicine. Evan Stein and colleagues report the results of two single-dose studies in which the drug, REGN727, was administered intravenously and subcutaneously to healthy subjects. In a [...]” View full resource at forbes.com
Most Recently Shared on March 22, 2012 at 1:51 am By:
Promising Phase 1 Results For New Monoclonal Antibody to PCSK9: Promising results from very early studies with a... http://t.co/9bbzTaec
Potential Treatment For Tumors Resistant To VEGF Therapy Offered By Novel Monoclonal Antibody
medicalnewstoday.com — “Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which is designed to shut down growth of new blood vessels that feed tumors and spread canc” View full resource at medicalnewstoday.com
Most Recently Shared on November 15, 2011 at 9:05 am By:
Potential Treatment For Tumors Resistant To VEGF Therapy Offered By Novel Monoclonal Antibody http://t.co/IVv8LjnF #liver #hepatitis
FDA Approves A New, Monoclonal Antibody For Lymphoma - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on August 29, 2011 at 9:24 pm By:
FDA Approves A New, Monoclonal Antibody For Lymphoma: Recently, the FDA announced its approval, upon acce... http://t.co/EB5I1vj #news
REGN727 Monoclonal Antibody Lowers LDL Cholesterol --Doctors Lounge
doctorslounge.com — “REGN727 Monoclonal Antibody Lowers LDL Cholesterol --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on March 22, 2012 at 12:16 am By:
REGN727 Monoclonal Antibody Lowers LDL Cholesterol http://t.co/EwMKLdLw #Health #Medicine
Endocrinology News - Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol |3991613
mdlinx.com — “Endocrinology Medical Article: Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol” View full resource at mdlinx.com
Most Recently Shared on March 24, 2012 at 8:15 am By:
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol: New England Journal of Medicine http://t.co/ZCz79c4j #endo
AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting
news-medical.net — “AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.” View full resource at news-medical.net
Most Recently Shared on March 28, 2011 at 3:19 pm By:
Oncology News: AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting: AVEO Ph... http://bit.ly/g0pgcu
Research and Markets: Cancer Monoclonal Antibodies Market to 2015 - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: DUBLIN-- -- Dublin - Research and Markets has announced the addition of the "Cancer Monoclonal Antibodies Market to 2015" report to their offering. Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease ...” View full resource at finance.yahoo.com
Most Recently Shared on March 23, 2012 at 1:07 pm By:
Research and Markets: Cancer Monoclonal Antibodies Market to 2015: DUBLIN-- -- Dublin - Research and Markets has... http://t.co/P5jBPFcz
Monoclonal Antibodies-Reports from Dartmouth University advance knowledge in...
newsrx.com — “World's Largest Source of Health Information. Health, Medical, Biotech, Legal, Business & Clinical Research News for Professionals and Knowledgeable Consumers.” View full resource at newsrx.com
Most Recently Shared on August 15, 2009 at 1:01 pm By:
Reports from Dartmouth University advance knowledge in monoclonal antibodies...http://bit.ly/CtpVb
Yervoy: a novel monoclonal antibody for the treatment of skin cancer. | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on August 31, 2011 at 8:30 am By:
New to MIMS for September: Yervoy, a monoclonal antibody for advanced melanoma: http://t.co/44nUVv5
Novel Monoclonal Antibody Offers Potential Treatment for Tumors Resistant to VEGF Therapy
aacr.org — “Shutting down the ALK-1 receptor inhibits the VEGF pathway. Response seen in patients who had used antiangiogenic therapy. VEGF therapies might work best in combination. SAN FRANCISCO — Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which is designed to shut down growth of new blood vessels that feed tumors and spread cancer cells. Now, a study reported at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer The” View full resource at aacr.org
Most Recently Shared on November 22, 2011 at 5:57 am By:
Novel Monoclonal Antibody PF-03446962 Offers Potential Treatment 4 Tumors Resistant 2 VEGF Therapy 2011 AACR-NCI-EORTC http://t.co/mI89ZZq6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
Advertisement

